Anti-phospholipid antibodies and CD5+ B cells in HIV infection

Clinical and Experimental Immunology

Volumn 115, Issue 3, 1999, Pages 464-471

  Grunewald T ^b   Burmester, G R ^a   Schuler Maue W ^b   Hiepe, F ^a   Buttgereit, F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Medizinische Univ Klin mS R ^*

Author keywords

Anti phospholipid antibodies; CD5+ B cells; Cross sectional study; HIV infection

Indexed keywords

CARDIOLIPIN ANTIBODY; CD5 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MEMBRANE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE SUBPOPULATION;

EID: 0032994340     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00828.x     Document Type: Article

References (51)

1. Pantaleo G, Fauci AC. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995; 15: 487-512.
2. Lane CH, Masur H, Edgar LC, Wahlen G, Rook G, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309: 453-8.
3. Pahwa S, Pahwa R, Saxinger C, Gallo RC, Good RA. Influences of human T lymphototropic virus/lymphdenopathy associated virus on human lymphocytes: evidence of polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci USA 1985; 82: 8198-202.
4. Schnittman SM, Lane CH, Higgins S, Folks T, Fauci AS. Direct polyclonal activation of human B lymphocytes by acquired immunodefciency syndrome virus. Science 1986; 233: 1084-6.
5. Chirmule N, Oyaizu N, Saxinger C, Pahwa S. Nef protein of HIV-1 has B-cell stimulatory activity. AIDS 1994; 8: 733-9.
6. Yarchoan R, Redfield RR, Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus type III/lymphadenopathy associated virus. J Clin Invest 1986; 78: 439-47.
7. Sonnabend J, Witkin SS, Purtillo DT. Acquired immunodefiency syndrome, opportunistic infections, and malignancies in male homosexuals, A hypothesis of etiologic factors in pathogenesis. JAMA 1983; 249: 2370-4.
8. Muller S, Richalet P, Laurent-Crawford A et al. Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS 1992; 6: 933-42.
9. Viard JP, Chabre H, Bach JF. Autoantibodies to nucleosomes in HIV-1-infected patients. J AIDS 1994; 7: 1286-7.
10. Pinching AJ. Antibody responses in HIV infection. Clin Exp Immunol 1991; 84: 181-4.
11. Asherson RA, Harris EN. Anticardiolipin antibodies-clinical associations. Postgrad Med J 1986; 62: 1081-7.
12. Hughes GRV, Asherson RA, Khamashta MA. Antiphospholipid syndrome-linking many specialities. Ann Rheum Dis 1989; 48: 355-6.
13. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematodes (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 692-8.
14. Sammaritano LR, Gharavi AE, Lockshin MD. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Sem Arthritis Rheum 1990; 20: 81-96.
15. Mackworth-Young CG, Loizou S, Walport MJ. Antiphospholipid antibodies and disease. Quart J Med 1989; 269: 767-77.
16. Thomas MA, Frampton G, Isenberg DA, Shoenfeld Y, Akinsola A, Ramzy M, Lilleywhite J, Williams DG. A common anti-DNA antibody isotype and antiphospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. J Autoimmun 1989; 2: 803-11.
17. Snowden M, Wilson PB, Longson M, Pumphrey RSH. Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J 1990; 66: 356-62.
18. Stimmler MM, Quismorio FP, McGehee WH, Boylen T, Sharma OP. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Int Med 1989; 149: 1833-5.
19. + B lymphocytes and the activity of systemic autoimmunity. Clin Immunol Immunopathol 1990; 56 219-25.
20. Schroeder HW, Dighiero W. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994; 15: 288-94.
21. Maini RN, Plater-Zyberk C, Andrew E. Autoimmunity in rheumatoid arthritis. An approach via a study of B lymphocytes. Rheum Dis Clin North Am 1987; 13: 319-38.
22. Dauphinee M, Tovar Z, Talal N. B cells expressing CD5 are increased in Sjögrens's syndrome. Arthritis Rheum 1988; 31: 642-7.
23. Smerdon RA, Peakman M, Hussain MF, Wong FS, Watkins PJ, Leslie RD, Vergani D. CD5+ B-cells at the onset of type 1 diabetes and in the prediabetic period. Diabetes Care 1994; 17: 657-64.
24. Capel P, Janssens A, Clumeck N, Gerard M, Feremans W, Vandevelde D, Fondu P. Anticardiolipin antibodies (ACA) are most often not associated with lupus-like anticoagulant (LLAC) in human immunodeficiency virus (HIV) infection. Am J Hematol 1991: 37: 234-8.
25. Coll Daroca J, Gutiérrez-Cebollada J, Yazbeck H, Bergés A, Rubié-Prat J. Anticardiolipin antibodies and acquired immunodeficiency syndrome: prognostic marker or association with HIV infection? Infection 1992; 20: 140-2.
26. Centers for Disease Control and Prevention. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infection. MMWR Morb Mortal Wkly Rep 1994; 43 (RR-3): 1-21.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-65.
28. Centers for Disease Control and Prevention. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41: 1-19.
29. Buttgereit F, Grünewald T, Schüler-Maué W, Burmester GR, Hiepe F. Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases. Clin Rheumatol 1997; 16: 562-9.
30. Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome. J Rheumatol 1992; 19: 1778-81.
31. Canoso RT, Zon LI, Groopman JE. Anticardiolipin antibodies associated with HTLV-III infection. Br J Jaematol 1987; 65: 495-8.
32. Weiss L, You JF, Giral P, Alhenc-Gelas M, Senger D, Kazatchkine MD. Anti-cardiolipin antibodies are associated with anti-endothelial cell antibodies but not with anti-beta 2 glycoprotein I antibodies in HIV infection. Clin Immunol Immunopathol 1995; 77: 69-74.
33. Oyaizu N, McCloskey TW, Than S, Hu R, Pahwa S. Mechanisms of apoptosis in peripheral blood mononuclear cells of HIV-infected individuals. Adv Exp Biol Med 1995; 374: 101-14.
34. Macho A, Castedo M, Marchetti P et al. Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficicncy virus-I carriers. Blood 1995; 86: 2481-7.
35. Devaux PF. Protein involvement in transmembrane lipid asymmetry. Ann Rev Biophys Biomol Struct 1992; 21: 417-39.
36. Ruetz S, Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 1994; 77: 1071-81.
37. Gollapudi S, Gupta S. Human immunodeficiency virus 1-induced expression of P-glycoprotein. Biochem Biophys Res Commun 1990; 171: 1002-7.
38. Gollapudi S, Gupta S. Mycobacterium tuberculosis induces expression of P-glycoprotein in promonocytic UI cells chronically infected with HIV-1. Biochem Biophys Res Commun 1994; 199: 1181-7.
39. Silvestris F, Frassanito MA, Cafforio P et al. Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxity. Blood 1996; 87: 5185-95.
40. Rubbert A, Bock D, Schwab J, Marienhagen J, Nuesslein H, Wolf F, Kalden JR. Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mRc-HMPAO SPECT. Clin Exp Immunol 1994; 98: 361-8.
41. Rusnak JM, Butzin C, McGlasson D, Blatt SP. False-positive rapid plasma reagin tests in human immunodeficiency virus infection and relationship to anticardiolipin antibody and serum immunoglobulin levels. J Infect Dis 1994; 169: 1356-9.
42. Chamley LW, McKay EJ, Patterson NS. Cofactor dependent and cofactor independent anticardiolipin antibodies. Thromb Res 1991; 61: 291-9.
43. Bevers EM, Galli M. Cofactors involved in the antiphospholipid syndrome. Lupus 1992; 1: 51-53.
44. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, Yasuda T, Koike T. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148: 3885-91.
45. Hunt JE, NcNeil HP, Morgan GJ, Crameri RM, Krilis SA. A phospholipid-beta-glycoprotein 1 complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not in infection. Lupus 1992; 1: 75-81.
46. Saitoh N, Tsukamoto M, Gohchi K, Asami K, Hashimoto M. Measurement of β2-glycoprotein I (apolipoprotein H)-independent anticardiolipin antibodies in HIV 1-positive and virus 1-negative hemophiliacs. Am J Hematol 1993; 43: 146-8.
47. Sampolo A, López-Gómez M, Jiménez-Alonso J, Ortiz F, Samaniego F, Garrido F. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease. Clin Immunol Immunopathol 1993; 66: 260-8.
48. Vuillier F, Scott-Algarra D, Tortevoye P, Pialoux G, Dighiero G. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients. Clin Exp Immunol 1991; 85: 476-80.
49. Casali P, Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B cell repertoire. Immunol Today 1989; 10: 364-8.
50. Casali P, Notkins AL. Probing the human B cell repertoire with EBV-polyreactive antibodies and CD5+ B lymphocytes. Ann Rev Immunol 1989; 7: 513-35.
51. Hayakawa K, Hardy R. Normal, autoimmune and malignant CD5+ B cells-the Ly- 1+ B lineage? Ann Rev Immunol 1988; 6: 197-218.